Cantrell Drug Recalls Norepinephrine Bags Due to Sterility Concerns
Cantrell Drug Company is recalling 3,039 bags of Norepinephrine Bitartrate 4 mg in 0.9% Sodium Chloride due to a lack of sterility assurance.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The FDA classified this recall as Class II. According to the severity rubric, an FDA Class II recall involving a significant hazard such as lack of sterility assurance in an injectable drug is categorized as Severe (Score 4).
Plain-English summary
Cantrell Drug Company is recalling 3,039 bags of Norepinephrine Bitartrate 4 mg Added to 0.9% Sodium Chloride 250 mL (16 mcg per mL) Single-Dose Bags. The recall is being conducted because of a lack of sterility assurance for the affected product.
The affected product is identified by NDC 52533-134-18. The recall includes specific lots with the following lot numbers and beyond-use dates: 10069 (7/24/2017), 10090 (7/26/2017), 10121 (7/31/2017), 10142 (8/3/2017), 10183 (8/8/2017), 10360 (8/31/2017), and 10443 (9/14/2017). The product was distributed nationwide within the United States.
Healthcare providers and patients should discontinue use of the affected lots and contact Cantrell Drug Company for further instructions. The FDA has classified this recall as Class II, indicating that use of, or exposure to, the violative product may cause temporary or medically reversible adverse health consequences.
The recalled product
- Product
- Norepinephrine Bitartrate 4 mg Added to 0.9% Sodium Chloride 250 mL (16 mcg per mL) Single-Dose Bag, Rx Only, Cantrell Drug Company 7321 Cantrell Rd. Little Rock, AR 72207 877-666-5222, NDC 52533-134-18
- Manufacturer
- Cantrell Drug Company
- Category
- Drug — Injectable
- Hazard
- Affected units
- 3,039
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (14)
- Lot #: 10069
- BUD: 7/24/2017
- 10090
- BUD: 7/26/2017
- 10121
- BUD: 7/31/2017
- 10142
- BUD: 8/3/2017
- 10183
- BUD: 8/8/2017
- 10360
- BUD: 8/31/2017
- 10443
- BUD: 9/14/2017
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 18 recalled by Cantrell Drug Company under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 18 products in this recall →Related recalls
Same manufacturer · Cantrell Drug Company
See all →- SevereCantrell Drug Company Recalls Rocuronium Bromide Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Succinylcholine Chloride Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Norepinephrine Bags Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Recalls Neostigmine Methylsulfate Injection Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
- SevereCantrell Drug Recalls Ephedrine Sulfate Syringes Due to Sterility Concerns
FDA (Drugs) · 2017-08-16
Same hazard · lack of sterility
See all →- HighRohto Cooling Eye Drops Max Strength Recalled Due to Sterility Concerns
FDA (Drugs) · 2026-07-29
- HighRohto Cooling Eye Drops Recalled Due to Lack of Assurance of Sterility
FDA (Drugs) · 2026-07-29
- SevereCleviprex Injectable Emulsion Recall Due to Sterility Assurance Concerns
FDA (Drugs) · 2026-07-22
- SeverePemetrexed for Injection recalled due to lack of sterility assurance
FDA (Drugs) · 2026-07-15
- SevereAzacitidine for Injection Recalled for Lack of Sterility Assurance
FDA (Drugs) · 2026-07-15